IFNA1 and systemic lupus erythematosus: Among the more specific SLE manifestations, an early study observed that patients with lupus psychosis have detectable levels of IFN-α in the cerebrospinal fluid (CSF) (80), which is intriguing given the observed neuropsychiatric adverse effects during IFN-α treatment (81).